BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37897199)

  • 21. A fine decision tree consisted of CK5/6, IMP3 and TTF1 for cytological diagnosis among reactive mesothelial cells, metastatic adenocarcinoma of lung and non-lung origin in pleural effusion.
    Yan J; Wei Q; Jian W; Liu J; Tang H; Ge J; Zhou J; Zhao T
    Int J Clin Exp Pathol; 2014; 7(9):5810-8. PubMed ID: 25337222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGFR mutations predict a favorable outcome for malignant pleural effusion of lung adenocarcinoma with Tarceva therapy.
    Guo H; Wan Y; Tian G; Liu Q; Kang Y; Li Y; Yao Z; Lin D
    Oncol Rep; 2012 Mar; 27(3):880-90. PubMed ID: 22134479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic efficacy of electron microscopy and pleural effusion cytology for the distinction of pleural mesothelioma and lung adenocarcinoma.
    Domínguez-Malagón H; Cano-Valdez AM; González-Carrillo C; Campos-Salgado YE; Lara-Garcia A; Lopez-Mejia M; Corona-Cruz JF; Arrieta O
    Ultrastruct Pathol; 2016; 40(5):254-60. PubMed ID: 27405014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Alterations in Patients with Pulmonary Adenocarcinoma Presenting with Malignant Pleural Effusion at the First Diagnosis.
    Rodriguez EF; Shabihkhani M; Carter J; Maleki Z
    Acta Cytol; 2017; 61(3):214-222. PubMed ID: 28538219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulated HMGB1 in the pleural effusion of non-small cell lung cancer (NSCLC) patients reduces the chemosensitivity of NSCLC cells.
    Ma Y; Kang S; Wu X; Han B; Jin Z; Guo Z
    Tumori; 2018 Oct; 104(5):338-343. PubMed ID: 28885675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CK5/6 in effusions: no difference between mesothelioma and pulmonary and nonpulmonary adenocarcinoma.
    Dejmek A
    Acta Cytol; 2008; 52(5):579-83. PubMed ID: 18833821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in Pleural Fluid Amylase Levels in Patients with Malignant Pleural Effusion Based on Cancer Type, Histologic Type, and Epidermal Growth Factor Receptor Mutations.
    Shimoda M; Tanaka Y; Morimoto K; Yoshimori K; Ohta K
    Intern Med; 2023 Dec; 62(24):3601-3607. PubMed ID: 37081679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expressions of 8-OH-dG, k-ras, and p53 genes in pleural effusion cells and their clinical significances].
    Fu XY; Bin XN; Tan M
    Ai Zheng; 2005 Mar; 24(3):345-8. PubMed ID: 15757539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WIF-1 promoter region hypermethylation as an adjuvant diagnostic marker for non-small cell lung cancer-related malignant pleural effusions.
    Yang TM; Leu SW; Li JM; Hung MS; Lin CH; Lin YC; Huang TJ; Tsai YH; Yang CT
    J Cancer Res Clin Oncol; 2009 Jul; 135(7):919-24. PubMed ID: 19085002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity.
    Roscilli G; De Vitis C; Ferrara FF; Noto A; Cherubini E; Ricci A; Mariotta S; Giarnieri E; Giovagnoli MR; Torrisi MR; Bergantino F; Costantini S; Fenizia F; Lambiase M; Aurisicchio L; Normanno N; Ciliberto G; Mancini R
    J Transl Med; 2016 Feb; 14():61. PubMed ID: 26928703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcription expression and clinical significance of dishevelled-3 mRNA and δ-catenin mRNA in pleural effusions from patients with lung cancer.
    Li XY; Liu SL; Cha N; Zhao YJ; Wang SC; Li WN; Wang EH; Wu GP
    Clin Dev Immunol; 2012; 2012():904946. PubMed ID: 22461838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions.
    Bruschini S; di Martino S; Pisanu ME; Fattore L; De Vitis C; Laquintana V; Buglioni S; Tabbì E; Cerri A; Visca P; Alessandrini G; Facciolo F; Napoli C; Trombetta M; Santoro A; Crescenzi A; Ciliberto G; Mancini R
    J Cell Physiol; 2020 Mar; 235(3):1877-1887. PubMed ID: 31397494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KRT6A Promotes EMT and Cancer Stem Cell Transformation in Lung Adenocarcinoma.
    Yang B; Zhang W; Zhang M; Wang X; Peng S; Zhang R
    Technol Cancer Res Treat; 2020; 19():1533033820921248. PubMed ID: 32329414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of seven stem-cell-associated markers in human airway biopsy specimens obtained via fiberoptic bronchoscopy.
    Li L; Yu H; Wang X; Zeng J; Li D; Lu J; Wang C; Wang J; Wei J; Jiang M; Mo B
    J Exp Clin Cancer Res; 2013 May; 32(1):28. PubMed ID: 23683495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
    Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples.
    Zou Y; Xu L; Tang Q; You Q; Wang X; Ding W; Zhao J; Ren G
    BMC Cancer; 2020 Apr; 20(1):344. PubMed ID: 32321471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Slug regulates E-cadherin expression in metastatic adenocarcinoma cells isolated from pleural fluid.
    Li XN; Fang CQ; Wang YL; Wang XR; Wang EH; Li JH
    Diagn Cytopathol; 2013 Jan; 41(1):9-14. PubMed ID: 21656704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association Between CD133 Expression and Prognosis in Human Lung Adenocarcinoma.
    Yamashita N; Oyama T; So T; Miyata T; Yoshimatsu T; Nakano R; Matsunaga W; Gotoh A
    Anticancer Res; 2021 Feb; 41(2):905-910. PubMed ID: 33517296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary tumour resection showed survival benefits for non-small-cell lung cancers with unexpected malignant pleural dissemination.
    Ren YJ; She YL; Dai CY; Jiang GN; Fei K; Chen C
    Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):321-6. PubMed ID: 26705302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.